North China Pharmaceutical Co Ltd (600812) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million ≈ $24.91 Million USD) by net assets (CN¥6.67 Billion ≈ $976.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600812 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

North China Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sify Technologies Limited NASDAQ:SIFY	0.001x
Bellring Brands LLC NYSE:BRBR	0.022x
Excelerate Energy Inc NYSE:EE	0.027x
Leedarson IoT Technology Inc SHG:605365	-0.025x
Athens Water Supply and Sewerage Company S.A AT:EYDAP	-0.011x
West China Cement Limited F:WFG1	0.040x
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret A.S. IS:EUPWR	-0.023x
Malakoff Corporation Bhd KLSE:5264	0.021x

Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see North China Pharmaceutical Co Ltd (600812) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.88 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $172.16 Million	0.171x	-7.24%
2024-12-31	CN¥6.67 Billion ≈ $976.71 Million	CN¥1.23 Billion ≈ $179.92 Million	0.184x	+12.77%
2023-12-31	CN¥6.27 Billion ≈ $917.56 Million	CN¥1.02 Billion ≈ $149.88 Million	0.163x	+1.30%
2022-12-31	CN¥6.23 Billion ≈ $911.41 Million	CN¥1.00 Billion ≈ $146.97 Million	0.161x	+7.75%
2021-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.05 Billion ≈ $153.68 Million	0.150x	+40.40%
2020-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥752.15 Million ≈ $110.06 Million	0.107x	-18.20%
2019-12-31	CN¥5.62 Billion ≈ $822.98 Million	CN¥732.97 Million ≈ $107.26 Million	0.130x	-7.23%
2018-12-31	CN¥5.51 Billion ≈ $806.58 Million	CN¥774.33 Million ≈ $113.31 Million	0.140x	+158.25%
2017-12-31	CN¥5.28 Billion ≈ $772.71 Million	CN¥287.25 Million ≈ $42.03 Million	0.054x	+164.46%
2016-12-31	CN¥5.29 Billion ≈ $774.28 Million	CN¥-446.53 Million ≈ $-65.34 Million	-0.084x	-463.04%
2015-12-31	CN¥5.27 Billion ≈ $771.13 Million	CN¥122.50 Million ≈ $17.92 Million	0.023x	+34.66%
2014-12-31	CN¥5.25 Billion ≈ $767.70 Million	CN¥90.56 Million ≈ $13.25 Million	0.017x	+153.00%
2013-12-31	CN¥4.15 Billion ≈ $606.67 Million	CN¥-135.03 Million ≈ $-19.76 Million	-0.033x	-112.90%
2012-12-31	CN¥4.18 Billion ≈ $611.39 Million	CN¥-63.92 Million ≈ $-9.35 Million	-0.015x	-108.83%
2011-12-31	CN¥1.31 Billion ≈ $192.27 Million	CN¥227.60 Million ≈ $33.30 Million	0.173x	+134.21%
2010-12-31	CN¥1.18 Billion ≈ $172.92 Million	CN¥-598.35 Million ≈ $-87.56 Million	-0.506x	-144.62%
2009-12-31	CN¥890.92 Million ≈ $130.37 Million	CN¥1.01 Billion ≈ $147.96 Million	1.135x	+74.64%
2008-12-31	CN¥1.67 Billion ≈ $244.43 Million	CN¥1.09 Billion ≈ $158.85 Million	0.650x	+42.40%
2007-12-31	CN¥1.46 Billion ≈ $213.02 Million	CN¥664.37 Million ≈ $97.22 Million	0.456x	+6.25%
2006-12-31	CN¥1.39 Billion ≈ $203.42 Million	CN¥597.12 Million ≈ $87.38 Million	0.430x	+179.39%
2005-12-31	CN¥1.46 Billion ≈ $213.37 Million	CN¥224.17 Million ≈ $32.80 Million	0.154x	-14.81%
2004-12-31	CN¥1.72 Billion ≈ $251.66 Million	CN¥310.39 Million ≈ $45.42 Million	0.180x	-14.31%
2003-12-31	CN¥2.76 Billion ≈ $403.19 Million	CN¥580.32 Million ≈ $84.92 Million	0.211x	-23.91%
2002-12-31	CN¥2.67 Billion ≈ $390.38 Million	CN¥738.50 Million ≈ $108.07 Million	0.277x	+103.57%
2001-12-31	CN¥2.70 Billion ≈ $395.23 Million	CN¥367.28 Million ≈ $53.74 Million	0.136x	+175.41%
2000-12-31	CN¥2.70 Billion ≈ $395.61 Million	CN¥133.49 Million ≈ $19.53 Million	0.049x	+135.17%
1999-12-31	CN¥2.66 Billion ≈ $389.44 Million	CN¥-373.62 Million ≈ $-54.67 Million	-0.140x	+17.86%
1998-12-31	CN¥1.91 Billion ≈ $279.75 Million	CN¥-326.74 Million ≈ $-47.81 Million	-0.171x	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.10 Billion

CN¥7.51 Billion CNY

Market Cap Rank

#8662 Global

#2152 in China

Share Price

CN¥4.38

Change (1 day)

+0.23%

52-Week Range

CN¥4.34 - CN¥7.01

All Time High

CN¥18.60